文献速递艾滋病与性传播感染

宫内暴露抗逆转录病毒药物的HIV暴露未感染儿童出生时及早期白细胞端粒长度

Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.
PubMed 文献 · J Infect Dis · 2018-01-01

该研究在加拿大队列中比较HIV暴露未感染(HEU)儿童与HIV未暴露未感染(HUU)儿童出生时及出生后3年内白细胞端粒长度(LTL)。结果显示出生时HEU儿童LTL不短于HUU儿童,两组LTL下降相似,母亲cART持续时间或类型与婴儿LTL缩短无关,齐多夫定预防未显著改变LTL。

要点

  • 出生时HEU儿童LTL不短于HUU儿童,女性婴儿LTL长于男性。
  • 母亲cART持续时间或类型与婴儿LTL缩短无关联。
  • HEU儿童LTL从出生至1岁快速缩短,之后趋缓。

核心结论

  • 从出生至3岁,HEU儿童LTL未受母亲HIV感染及cART暴露的负面影响,至少在本加拿大队列所用方案下如此。

研究设计与样本

  • 横断面比较出生时及出生后3年内HEU与HUU儿童的血液LTL。
  • 出生时HEU儿童114例、HUU儿童86例。
  • 214例HEU儿童按年龄和性别1:1匹配HUU儿童进行LTL动态比较。
  • 对HEU儿童同一时期进行纵向LTL动态评估。

主要发现

  • 出生时HEU儿童LTL不短于HUU儿童,女性婴儿LTL长于男性婴儿。
  • 母亲cART持续时间或类型与婴儿LTL缩短无关联。
  • 匹配的214例HEU与HUU儿童LTL下降相似。
  • 纵向分析中HEU儿童LTL从出生至1岁快速缩短,之后逐渐缩短。
  • 齐多夫定预防未显著改变LTL。

临床怎么用

  • 提示临床对宫内暴露cART的HEU儿童端粒长度无需过度担忧,但仍需结合具体用药方案评估。
  • 随访中可关注出生后第一年LTL快速缩短的动态变化。

局限性

  • 结论基于加拿大队列所用cART方案,外推至其他人群或方案需谨慎。
  • 原文未报告具体LTL数值、随访失访率等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal combination antiretroviral therapy (cART) during pregnancy could impact the health of human immunodeficiency virus (HIV)-exposed, HIV-uninfected (HEU) children, because some antiretrovirals cross the placenta and can inhibit telomerase. Our objective was to compare leukocyte telomere length (LTL) in HEU children and HIV-unexposed, HIV-uninfected (HUU) children at birth and in early life and to investigate any relationship with cART exposure. METHODS: HEU and HUU children's blood LTL was compared cross-sectionally at birth, and during the first three years of life. Longitudinal HEU LTL dynamics was evaluated over that same period. RESULTS: At birth, the LTL in HEU children (n = 114) was not shorter than that in HUU children (n = 86), but female infants had longer LTL than male infants. Maternal cART (duration or type) showed no association with shorter infant LTL. Among 214 HEU children age- and sex-matched at a 1:1 ratio to HUU children, LTL declined similarly in both groups. In a longitudinal analysis, LTL attrition in HEU children was rapid from birth to 1 year of age and gradual thereafter. Zidovudine prophylaxis did not significantly alter LTL. CONCLUSIONS: Our results indicate that from birth to 3 years of age, the LTL in HEU children is not negatively affected by exposure to maternal HIV infection and cART, at least not to the regimens used within this Canadian cohort, a reassuring finding.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ajaykumar A, Soudeyns H, Kakkar F, et al. Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals. J Infect Dis. 2018. PMID: 29228317. doi:10.1093/infdis/jix618

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。